Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brian Booth

Bioanalysis

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Bioanalysis|May 7, 2011
Incurred sample reanalysisBrian Booth
Bioanalysis|December 22, 2011
When do you need a validated assay?Brian Booth
Bioanalysis|November 19, 2010
Bioanalysis: the best of 2009Brian Booth, Howard Hill
Bioanalysis|July 7, 2011
Utilization of electronic resources in the NDA/BLA regulatory review of bioanalytical data: perspectives from US FDA reviewersStanley Au, Chongwoo Yu, Brian Booth
Bioanalysis|November 19, 2010
Bioanalysis: Young Investigator 2010Brian Booth, Howard Hill, Ryan De Vooght-Johnson
Bioanalysis|May 7, 2013
Bioanalysis of antibody-drug conjugates: American Association of Pharmaceutical Scientists Antibody-Drug Conjugate Working Group position paperBoris Gorovits, Stephen C Alley, Sanela Bilic, et al.
Bioanalysis|February 7, 2012
US FDA/EMA harmonization of their bioanalytical guidance/guideline and activities of the Global Bioanalytical ConsortiumFabio Garofolo, Josée Michon, Virginie Leclaire, et al.
Bioanalysis|October 11, 2012
2012 white paper on recent issues in bioanalysis and alignment of multiple guidelinesBinodh DeSilva, Fabio Garofolo, Mario Rocci, et al.
Bioanalysis|December 14, 2019
2019 White Paper On Recent Issues in Bioanalysis: FDA BMV Guidance, ICH M10 BMV Guideline and Regulatory Inputs (<u>Part 2</u> - Recommendations on 2018 FDA BMV Guidance, 2019 ICH M10 BMV Draft Guideline and Regulatory Agencies' Input on Bioanalysis, Biomarkers and Immunogenicity)Brian Booth, Lauren Stevenson, Renuka Pillutla, et al.
Bioanalysis|October 11, 2013
2013 White Paper on recent issues in bioanalysis: 'hybrid'--the best of LBA and LCMSLauren Stevenson, Fabio Garofolo, Binodh DeSilva, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Bioanalysis|May 7, 2011
Incurred sample reanalysisBrian Booth
Bioanalysis|December 22, 2011
When do you need a validated assay?Brian Booth
Bioanalysis|November 19, 2010
Bioanalysis: the best of 2009Brian Booth, Howard Hill
Bioanalysis|July 7, 2011
Utilization of electronic resources in the NDA/BLA regulatory review of bioanalytical data: perspectives from US FDA reviewersStanley Au, Chongwoo Yu, Brian Booth
Bioanalysis|November 19, 2010
Bioanalysis: Young Investigator 2010Brian Booth, Howard Hill, Ryan De Vooght-Johnson
Bioanalysis|May 7, 2013
Bioanalysis of antibody-drug conjugates: American Association of Pharmaceutical Scientists Antibody-Drug Conjugate Working Group position paperBoris Gorovits, Stephen C Alley, Sanela Bilic, et al.
Bioanalysis|February 7, 2012
US FDA/EMA harmonization of their bioanalytical guidance/guideline and activities of the Global Bioanalytical ConsortiumFabio Garofolo, Josée Michon, Virginie Leclaire, et al.
Bioanalysis|October 11, 2012
2012 white paper on recent issues in bioanalysis and alignment of multiple guidelinesBinodh DeSilva, Fabio Garofolo, Mario Rocci, et al.
Bioanalysis|December 14, 2019
2019 White Paper On Recent Issues in Bioanalysis: FDA BMV Guidance, ICH M10 BMV Guideline and Regulatory Inputs (<u>Part 2</u> - Recommendations on 2018 FDA BMV Guidance, 2019 ICH M10 BMV Draft Guideline and Regulatory Agencies' Input on Bioanalysis, Biomarkers and Immunogenicity)Brian Booth, Lauren Stevenson, Renuka Pillutla, et al.
Bioanalysis|October 11, 2013
2013 White Paper on recent issues in bioanalysis: 'hybrid'--the best of LBA and LCMSLauren Stevenson, Fabio Garofolo, Binodh DeSilva, et al.
Pageof 1